The estimated Net Worth of Baiju R. Shah is at least $448 Thousand dollars as of 6 August 2021. Mr. Shah owns over 6,948 units of Invacare stock worth over $54,691 and over the last 13 years he sold IVC stock worth over $137,658. In addition, he makes $255,270 as Independent Director at Invacare.
Baiju has made over 6 trades of the Invacare stock since 2013, according to the Form 4 filled with the SEC. Most recently he sold 6,948 units of IVC stock worth $59,058 on 6 August 2021.
The largest trade he's ever made was selling 6,948 units of Invacare stock on 6 August 2021 worth over $59,058. On average, Baiju trades about 847 units every 151 days since 2011. As of 6 August 2021 he still owns at least 82,865 units of Invacare stock.
You can see the complete history of Mr. Shah stock trades at the bottom of the page.
Baiju R. Shah J.D. serves as Independent Director of the Company. Mr. Shah served as the Chief Executive Officer and a Director of BioMotiv, LLC, a company focused on developing a portfolio of drug discoveries from research institutions into new medicines from August 2012 until February 2019. Prior to that, Mr. Shah served as President and Chief Executive Officer and a Director of BioEnterprise Cleveland from 2004 to August 2012, Senior Vice President from 2003 to 2004 and a Vice President from 2002 to 2003. BioEnterprise is a Cleveland-based business formation, recruitment and acceleration initiative designed to grow health care companies and commercialize biomedical technologies. Prior to BioEnterprise, Mr. Shah worked for McKinsey & Company, where he was a leader in its Growth and Business Building practice. In addition, Mr. Shah served as a member of the Citizens Financial Group (NYSE: CFG) advisory board. Mr. Shah also serves as a Director of multiple privately held biomedical-related companies in which BioMotiv, LLC has investments.
As the Independent Director of Invacare, the total compensation of Baiju Shah at Invacare is $255,270. There are 10 executives at Invacare getting paid more, with Matthew Monaghan having the highest compensation of $8,340,920.
Baiju Shah is 48, he's been the Independent Director of Invacare since 2011. There are 18 older and no younger executives at Invacare. The oldest executive at Invacare Corp. is Susan Alexander, 63, who is the Independent Director.
Baiju's mailing address filed with the SEC is ONE INVACARE WAY, , ELYRIA, OH, 44035.
Over the last 21 years, insiders at Invacare have traded over $3,551,958 worth of Invacare stock and bought 391,450 units worth $2,325,949 . The most active insiders traders include Edward F Crawford, Aaron Malachi Iii Mixon, and Steven H Azurite Management.... On average, Invacare executives and independent directors trade stock every 52 days with the average trade being worth of $10,700. The most recent stock trade was executed by Steven H Azurite Management... on 17 November 2022, trading 122,820 units of IVC stock currently worth $47,900.
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the Company designs, manufactures, and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The Company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The Company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The Company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia Pacific.
Invacare executives and other stock owners filed with the SEC include: